发明名称 Methods and compositions for treating prostate cancer
摘要 Treatment of prostate cancer by regional and prolonged release of one or more nucleotide-based RNAi agents is provided.
申请公布号 US9006199(B2) 申请公布日期 2015.04.14
申请号 US201213676581 申请日期 2012.11.14
申请人 Silenseed Ltd. 发明人 Shemi Amotz;Zorde Khvalevsky Elina;Malka Gabai Rachel
分类号 A61K47/34;C12N15/113;C07H21/02;A61K9/00;A61K9/70;A61K31/713;A61K45/06;A61N5/10;C12N15/11 主分类号 A61K47/34
代理机构 JMB Davis Ben-David 代理人 JMB Davis Ben-David
主权项 1. A millimeter-scale drug delivery device (DDD) comprising: A biodegradable polymeric matrix comprising a mixture of polylactic acid (PLA) and polyglycolic acid (PGA), wherein the PLA:PGA ratio is 50:50, or between 65:35 and 95:5, inclusive; and An RNAi (RNA interference) agent incorporated within said biodegradable polymeric matrix, wherein the RNAi agent comprises a sense strand and an antisense strand, and wherein the sequences of the sense strand and the antisense strand target a gene sequence selected from the group consisting of SEQ ID NO: 14 (NETO2), SEQ ID NO: 20 (PTPRA), and SEQ ID NO: 31 (Brd4).
地址 Jerusalem IL